ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed

December 12, 1975

Can NCI Fund 4-Year Grants With 2-Year Stimulus Funds?

March 6, 2009

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Congress Approves Payments For Treatment Of Women Diagnosed In CDC Program.

October 13, 2000

SBIR Priority Score Median Must Match R01s Under House Bill

June 28, 1996